LADCX | Developing Growth Fund Class C | Lord Abbett
Image alt tag

Error!

There was a problem contacting the server. Please try after sometime.

Sorry, we are unable to process your request.

Error!

We're sorry, but the Insights and Intelligence Tool is temporarily unavailable

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Error!

We're sorry, but the Literature Center checkout function is temporarily unavailable.

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

Reset Your Password

Financial Professionals*

Your password must be a minimum of characters.

Confirmation Message

Your LordAbbett.com password was successully updated. This page will be refreshed after 3 seconds.

OK

 

Developing Growth Fund

Summary

Summary

What is the Developing Growth Fund?

The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of small U.S. companies.

 

Fund Basicsas of 03/31/2021

Total Net Assets
$5.23 B
Inception Date
08/01/1996
Dividend Frequency
Annually
Fund Expense Ratio
1.68%
Number of Holdings
104
Minimum Initial Investment
$1,000+

Fund Expense Ratio :

1.68%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 08/01/1996
w/o sales charge 1.45% 109.49% 30.38% 26.94% 15.33% 11.15%
Lipper Category Avg. Small-Cap Growth Funds 6.06% 92.77% 19.82% 19.91% 13.10% -
Russell 2000® Growth Index 4.88% 90.20% 17.16% 18.61% 13.02% 8.59%
w/ sales charge 0.45% 109.49% 30.38% 26.94% 15.33% 11.15%

Fund Expense Ratio :

1.68%

Fund Expense Ratio :

1.68%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 08/01/1996
w/o sales charge 1.45% 109.49% 30.38% 26.94% 15.33% 11.15%
Lipper Category Avg. Small-Cap Growth Funds 6.06% 92.77% 19.82% 19.91% 13.10% -
Russell 2000® Growth Index 4.88% 90.20% 17.16% 18.61% 13.02% 8.59%
w/ sales charge 0.45% 109.49% 30.38% 26.94% 15.33% 11.15%

Fund Expense Ratio :

1.68%

TEN LARGEST HOLDINGS as of 03/31/2021View Portfolio

Holding Assets
Inspire Medical Systems Inc 2.2%
Sonos Inc 2.0%
LGI Homes Inc 1.9%
MKS Instruments Inc 1.9%
Western Alliance Bancorp 1.9%
Natera Inc 1.8%
Axonics Modulation Technologies Inc 1.7%
RH 1.7%
Shift4 Payments Inc 1.7%
Axon Enterprise, Inc. 1.6%

INVESTMENT TEAM

F. Thomas O'Halloran
F. Thomas O'Halloran, CFA, J.D.

Partner & Portfolio Manager

33 Years of Industry Experience

Matthew R. DeCicco
Matthew R. DeCicco, CFA

Partner & Director of Equities

21 Years of Industry Experience

Vernon Bice
Vernon Bice, CMT

Portfolio Manager

19 Years of Industry Experience

Ben Ebel
Ben Ebel

Portfolio Manager

28 Years of Industry Experience

Supported By 5 Investment Professionals with 18 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Fund Expense Ratio :

1.68%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 08/01/1996
w/o sales charge 1.45% 109.49% 30.38% 26.94% 15.33% 11.15%
Lipper Category Avg. Small-Cap Growth Funds 6.06% 92.77% 19.82% 19.91% 13.10% -
Russell 2000® Growth Index 4.88% 90.20% 17.16% 18.61% 13.02% 8.59%
w/ sales charge 0.45% 109.49% 30.38% 26.94% 15.33% 11.15%

Fund Expense Ratio :

1.68%

Fund Expense Ratio :

1.68%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 08/01/1996
w/o sales charge 1.45% 109.49% 30.38% 26.94% 15.33% 11.15%
Lipper Category Avg. Small-Cap Growth Funds 6.06% 92.77% 19.82% 19.91% 13.10% -
Russell 2000® Growth Index 4.88% 90.20% 17.16% 18.61% 13.02% 8.59%
w/ sales charge 0.45% 109.49% 30.38% 26.94% 15.33% 11.15%

Fund Expense Ratio :

1.68%

Year Fund Returns Russell 2000® Growth Index
2020 71.28% 34.63%
2019 30.89% 28.48%
2018 4.21% -9.31%
2017 28.93% 22.17%
2016 -3.42% 11.32%
2015 -9.54% -1.38%
2014 2.54% 5.60%
2013 56.21% 43.30%
2012 9.65% 14.59%
2011 -2.28% -2.91%
2010 35.64% -
2009 45.99% -
2008 -47.80% -
2007 34.99% -
2006 11.72% -
2005 11.17% -
2004 5.30% -
2003 39.19% -
2002 -29.77% -
2001 -7.50% -
Year Q1 Q2 Q3 Q4 Yearly Returns
2021 1.45% - - - 3.91%
2020 -17.05% 40.26% 15.73% 27.21% 71.28%
2019 26.77% 8.84% -11.52% 7.22% 30.89%
2018 6.93% 14.67% 11.95% -24.08% 4.21%
2017 8.12% 3.89% 6.83% 7.44% 28.93%
2016 -10.48% 1.99% 10.69% -4.44% -3.42%
2015 6.93% 2.46% -15.88% -1.84% -9.54%
2014 1.50% 0.00% -5.91% 7.37% 2.54%
2013 13.37% 9.85% 18.53% 5.82% 56.21%
2012 12.02% -2.84% 5.36% -4.39% 9.65%
2011 10.09% 1.34% -21.01% 10.88% -2.28%
2010 7.98% -8.05% 16.30% 17.47% 35.64%
2009 -2.39% 24.20% 13.99% 5.65% 45.99%
2008 -21.94% 6.47% -11.96% -28.66% -47.80%
2007 4.56% 13.34% 9.71% 3.83% 34.99%
2006 15.79% -6.35% -6.95% 10.72% 11.72%
2005 -6.02% 5.63% 9.47% 2.30% 11.17%
2004 1.88% 0.00% -7.18% 11.35% 5.30%
2003 -3.39% 21.08% 9.62% 8.55% 39.19%
2002 -0.14% -11.73% -23.96% 4.78% -29.77%
2001 -17.58% 15.83% -22.77% 25.47% -7.50%
2000 3.35% -13.77% -0.69% -7.52% -18.16%
1999 1.24% 11.49% -3.50% 25.96% 37.21%
1998 11.37% -3.10% -22.18% 28.08% 7.56%
1997 -3.14% 17.51% 21.55% -6.24% 29.72%
1996 - - - 7.31% 14.56%

NAV Historical Prices

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioning as of 12/31/2020

  • Our view of the market remains positive.  While we are optimistic about equity returns in 2021, we acknowledge the likelihood of increased volatility as rising COVID cases and political uncertainty come back to the forefront.
  • Over the latter part of 2020, we adjusted the portfolio to be more balanced between secular and cyclical growth stocks, which we view as appropriate at this point in the stock market and economic recovery cycle.
  • However, we continue to believe that industries powering the technology revolution – from the cloud to artificial intelligence to biotechnology, medical devices, and ecommerce – are best positioned to weather and benefit from the innovative environment that will likely persist for years.
  • Moreover, unlike many other areas of the economy, we believe that these targeted areas of innovation should continue to exhibit fundamental strength and have the potential for greater relative performance through an economic slowdown, as they continue to displace older businesses and outdated technologies.
  • We believe the backdrop for innovation investing remains favorable because of continued low economic growth and low inflation; in addition, the technology revolution is still in its early stages.

Portfolio Details as of 03/31/2021

Total Net Assets
$5.23 B
Number of Holdings
104
Weighted Average Market Cap.
5.7 B
P/B Ratio
7.4x
P/E Ratio
36.3x

Contributors & Detractors as of  03/31/2021

Contributors

Holding Contribution
Macerich Co. 0.8%
Sonos Inc 0.6%
Western Alliance Bancorp 0.6%
LGI Homes, Inc. 0.5%
Digital Turbine Inc 0.5%

Detractors

Holding Contribution
Cardlytics Inc -0.4%
Berkeley Lts Inc -0.3%
Trupanion Inc -0.3%
Iovance Biotherapeutics -0.3%
Turning Point Therapeut -0.3%

Attribution Analysis 

Developing Growth Fund Benchmark Variance
Sector Avg. Weight Base Return Avg. Weight Base Return Stock Selection Group Weight Total

Dividends & Cap Gains

Dividends & Cap Gains

Upcoming Dividend Payment Dates

This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date Reinvest & Payable Date
11/22/2021 11/23/2021 11/23/2021

Capital Gains Distributions

For
Record Date Reinvest & Payable Date Long-term Short-term * Total Reinvest Price
11/23/2020 11/24/2020 $2.1959 $0.7588 $2.9547 $14.15

Upcoming Capital Gain Distribution

This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date
11/22/2021 11/23/2021

Fees & Expenses

Fees & Expenses

Expense Ratioas of 03/31/2021

1.68%

Fund Documents

Fund Documents

Download fund documents & literature, create email subscriptions, and place direct mail order

0Documents selected
Order
n/a
Portfolio Holdings 1Q
Publish Date:11/03/2015
n/a
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
n/a
Statutory Prospectus
Publish Date:11/03/2015
n/a
Prospectus (XBRL)
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015
Fund Story
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

The Russell 2000® Growth Index measures the performance of those Russell 2000 companies with higher price-to-book ratios and higher forecasted growth values.

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field